| 000 | 02322nam a22002297a 4500 | ||
|---|---|---|---|
| 005 | 20231026142137.0 | ||
| 008 | 231026b ph ||||| |||| 00| 0 eng d | ||
| 022 | _a0361-929x | ||
| 040 | _cOCT | ||
| 100 | _aVignito, Julie | ||
| 240 |
_aNursing 2023 / _hJuly/August 2023 |
||
| 245 |
_aOver-the -counter pain medication use during pregnancy / _cJulie Vignato, Brooke Mehner, Alondra Negrete, and Lisa S. Segre |
||
| 260 |
_aHagerstown, MD : _bWolters Kluwer Health, _c2023 |
||
| 300 | _aVol 48(4) : pages 209-214 | ||
| 505 | _aABSTRACT : Purpose: To examine over-the -counter pain medication use in pregnancy. Study Design and Methods: Secondary analysis of a weighted surveillance survey using the 2019 Iowa Pregnancy Risk Assessment Monitoring System (PRAMS) data. A sample of 759 pregnant women of childbearing age from Iowa was weighted to represent 31, 728 Iowa mothers. The weighted sample represents 80% non-Hispanic White mothers, with smaller precentages of HIspanic Balck(7% ) mothers, consistent with the population of Iowa. Approximately two-thirds of women had commercial insurance (66%), some college or greated education (62%), and were from urban areas (59%). Analysis : Descriptive statistics were calculated.Variables include over-the-counter pain relievers usage among all respondents and by race/ethnicity and education level. Results: Seventy-six percent of women reported taking over-the counter pain reliever during pregnancy. Of these 71% reported taking acetaminophen, 11% reported taking ibuprofen, 8% aspirin, and 3% naproxen. Nearly 80% of non-Hispanic white mothers with an over-the -counter pain reliever during pregnancy compared to just 64% of mothers reported as Hispanic.Iowa mothers with college education or greater were more likely to report over-the -counter pain reliever use during pregnancy (84%) than their counterparts with a high school education or less (64%) . Clinical Implications: Some medications may cause harm to the fetus if taken at specific time during pregnancy. Reinforcement of current pain medication education, including risks to fetus throughout pregnancy may be needed . | ||
| 650 | _aOver-the -counter | ||
| 650 | _aMedication | ||
| 700 | _aMehner, Brooke | ||
| 700 | _aNegrete, Alondra | ||
| 700 | _aSegre, Lisa S. | ||
| 942 |
_2ddc _cCR _n0 |
||
| 999 |
_c9302 _d9302 |
||